RBC Capital Maintains Outperform on Elevance Health, Lowers Price Target to $478

Benzinga · 10/18 13:06
RBC Capital analyst Ben Hendrix maintains Elevance Health (NYSE:ELV) with a Outperform and lowers the price target from $585 to $478.